Who owns PDL BioPharma?

Key details on PDL BioPharma (Ticker: PDLI)

Who owns PDL BioPharma?

Is PDLI a good stock to own? Find out who bought PDL BioPharma, who sold PDL BioPharma (PDLI) stock, and who holds a large position in PDL BioPharma.

Fund Name Number of Shares Share Valuation As Of
First Trust Advisors 14.11M $99.21M March 31, 2015
BlackRock Fund Advisors 13.36M $93.95M March 31, 2015
Renaissance Technologies 11.97M $84.28M March 31, 2015
Vanguard 11.52M $81.00M March 31, 2015
Schroder Investment Management 8.68M $66.96M Dec. 31, 2014
Baupost 8.00M $49.60M Dec. 31, 2011
Acadian Asset Management 6.46M $45.45M March 31, 2015
FMR 6.37M $49.20M June 30, 2013
Advisors Asset Management 5.30M $37.29M March 31, 2015
Bank of America Corporation 4.88M $37.59M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 4.66M $32.77M March 31, 2015
STATE STREET CORPORATION 3.80M $26.73M March 31, 2015
Inves 3.58M $27.61M Dec. 31, 2014
Gotham Asset Management 3.37M $23.66M March 31, 2015
Wells Fargo & Company 3.22M $24.79M Dec. 31, 2014
AQR Capital Management 2.98M $22.97M June 30, 2013
MSDC Management 2.86M $18.94M June 30, 2012
OppenheimerFunds 2.82M $18.71M June 30, 2012
Hussman Econometrics Advisors 2.81M $21.69M June 30, 2013
Two Sigma Advisers 2.80M $21.52M Sept. 30, 2012
DIMENSIONAL FUND ADVISORS 2.69M $18.94M March 31, 2015
NORTHERN TRUST 2.69M $20.01M Sept. 30, 2014

Who sold PDL BioPharma?

Fund Name Date Sold Number of Shares Sold Share Valuation
First Eagle Investment Management Dec. 31, 2010 3.55M $22.12M
Paulson & Co March 31, 2008 5.40M $57.16M